DUSP9

DUSP9

Target · MAP kinase phosphatase

DUSP9 Dual specificity phosphatase 9 · MKP-4

DUSP9 (dual specificity phosphatase 9, also known as MKP-4 or MKP4) is a MAP kinase phosphatase that inactivates MAP kinases, with a specificity for the ERK family. It belongs to the non-receptor class dual specificity subfamily of the protein-tyrosine phosphatase family. Browse Assay Genie's current range of DUSP9 research reagents below, or read on for the biology behind the target.

Cytoplasmic phosphataseInactivates ERK-family kinasesLinked to type 2 diabetes
384 aa
Protein length
~42 kDa
Molecular weight
Xq28
Gene locus
EC 3.1.3.16
Enzyme class
Target information

What is DUSP9 (dual specificity phosphatase 9)?

DUSP9 is a member of the dual specificity protein phosphatase subfamily. These enzymes inactivate their target kinases by dephosphorylating both phosphoserine/threonine and phosphotyrosine residues. In this way they act as negative regulators of the mitogen-activated protein (MAP) kinase superfamily, which includes MAPK/ERK, SAPK/JNK and p38, and which is associated with cellular proliferation and differentiation. The DUSP9 protein shows selectivity for members of the ERK family of MAP kinases.

Different dual specificity phosphatases show distinct substrate specificities for individual MAP kinases, as well as different tissue distribution, subcellular localisation and modes of inducibility by extracellular stimuli. DUSP9 is localised to the cytoplasm and nucleus, with UniProt annotating a cytoplasmic location. The DUSP9 gene lies on the X chromosome, and alternate splicing results in multiple transcript variants. Researchers studying this enzyme may use a DUSP9 antibody or DUSP9 ELISA kit alongside other approaches to follow expression.

The protein is also known as MKP-4 (MAP kinase phosphatase 4), and HGNC classes it within the MAP kinase phosphatases gene group. Aberrant expression of the DUSP9 gene has been associated with type 2 diabetes and with cancer progression in several cell types, which makes it a point of interest for work on MAP kinase signalling control in metabolic disease and oncology.

MAPK/ERK signalling

DUSP9 inactivates MAP kinases with specificity for the ERK family, making it a tool for studying negative regulation of this pathway.

Type 2 diabetes research

Aberrant DUSP9 expression is associated with type 2 diabetes, so the phosphatase is studied in metabolic disease.

Cancer progression studies

Altered expression of DUSP9 is linked to cancer progression in several cell types, prompting investigation of its role in tumour biology.

Proliferation and differentiation

By dephosphorylating MAP kinases tied to proliferation and differentiation, DUSP9 helps define how these cellular programmes are restrained.

Background

DUSP9 frequently asked questions

What does DUSP9 do?

DUSP9 inactivates MAP kinases, showing specificity for the ERK family. As a dual specificity phosphatase it removes phosphate groups from both phosphoserine/threonine and phosphotyrosine residues, so it negatively regulates MAP kinase signalling linked to cell proliferation and differentiation.

What other names does DUSP9 go by, and does it have isoforms?

DUSP9 is also known as MKP-4 or MKP4, and its full name is dual specificity phosphatase 9. UniProt lists it as dual specificity protein phosphatase 9. NCBI Gene reports that alternate splicing results in multiple transcript variants.

Is DUSP9 linked to disease?

NCBI Gene reports that aberrant expression of DUSP9 is associated with type 2 diabetes and with cancer progression in several cell types. Mouse and rat orthologs are not specified in the supplied data, so check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other dual specificity phosphatases and MAP kinase phosphatases with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q99956; product specifications from Assay Genie datasheets.

DUSP9 Product listing